헬스케어 처방적 분석 : 시장 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, healthcare prescriptive analytics market size in 2026 is estimated at USD 20.17 billion, growing from 2025 value of USD 16.17 billion with 2031 projections showing USD 60.88 billion, growing at 24.73% CAGR over 2026-2031.

This report is Segmented by Application (Clinical Decision Support, Financial Analytics, and More), Product (Hardware, Software, and Services), Deployment Model (On-Premise, and More), End User (Healthcare Providers, and More), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Healthcare Prescriptive Analytics Market Trends and Insights

Integration of Big Data and AI in Healthcare

Health systems recognize that traditional analytics cannot process the velocity and complexity of genomic data, continuous monitoring feeds, and unstructured clinical notes. Platforms that fuse large-scale data pipelines with artificial intelligence now deliver prescriptive recommendations in real time. Epic Systems' 2024 release of its AI Trust and Assurance Suite gives hospitals tools to test and monitor algorithm performance before clinical deployment. As these capabilities mature, clinicians transition from retrospective reporting to point-of-care interventions that personalize treatment based on patient-specific risk signals. Early adopters report higher diagnostic accuracy and targeted therapeutic selection, provided data quality and workflow integration hurdles are addressed.

Growing Need for Cost Containment and Operational Efficiency

Labor costs approach 50% of total hospital expenses while patient volumes remain volatile. Prescriptive analytics models shorten revenue-cycle timelines, optimize staffing rosters, and reduce supply chain waste. The American Hospital Association estimates that 25% of U.S. healthcare spending is lost to administrative inefficiencies. Real-time location systems coupled with analytics dashboards keep track of beds, clinicians, and high-value equipment, enabling dynamic resource allocation that lowers operational expenses and frees capacity for higher-acuity cases.

Data Security and Compliance Challenges

The European Union's Artificial Intelligence Act now classifies clinical AI as high-risk, mandating transparency and oversight. Simultaneously, the European Health Data Space regulation approved in March 2025 introduces cross-border sharing rules while preserving patient privacy. These frameworks raise compliance hurdles, forcing vendors to hard-wire audit trails, consent engines, and de-identification modules into analytics platforms. Hospitals that lack robust privacy controls face implementation delays and potential penalties.

Other drivers and restraints analyzed in the detailed report include:

1. Incentives for Value-Based Care and Outcome-Focused Reimbursement
2. Rise of Patient Digital Twins for Therapy Optimization
3. Shortage of Analytics Talent in Clinical Settings

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Clinical Decision Support applications generated the most significant revenue in 2025, capturing 45.72% of the healthcare prescriptive analytics market. Hospitals prioritize decision support to reduce medication errors and standardize evidence-based protocols, while funding initiatives such as the U.S. real-time prescription benefit program stimulate adoption at the point of care. Research & Population Health Analytics is the fastest-growing application, expanding at a 26.31% CAGR as payers and providers shift toward proactive, community-level interventions. Population-scale datasets such as Epic Cosmos, which holds de-identified records for more than 246 million individuals, illustrate the scale required to model disease patterns and inform public-health actions.

The convergence of individual-level decision support with population analytics lets organizations derive insights across macro and micro lenses. Integrated platforms that map care pathways for single patients and entire cohorts are increasingly favored, supporting both treatment personalization and regional health-planning efforts.

Services accounted for 63.77% of the healthcare prescriptive analytics market size in 2025 and are forecast to post a 26.03% CAGR through 2031. Complex regulatory frameworks, legacy EHR environments, and clinician adoption hurdles make implementation know-how more valuable than the underlying software. Software licenses remain essential yet are frequently bundled with long-term advisory and managed services agreements. Hardware spending focuses on high-performance storage and GPUs that support training and inference workloads.

Health systems such as Duke Health have entered multi-year partnerships with analytics vendors to access specialized expertise while reducing internal burdens. These service-oriented models provide hospitals with sustained guidance on model governance, workflow redesign, and change management.

Complete Report Scope:

• By Application
  • Clinical Decision Support
  • Financial Analytics
  • Administrative / Operational Analytics
  • Research & Population Health Analytics
• By Product
  • Hardware
  • Software
  • Services
• By Deployment Model
  • On-Premise
  • Cloud-Based
  • Hybrid
• By End User
  • Healthcare Providers
  • Healthcare Payers
  • Pharmaceutical & Life-Sciences Companies
  • Government & Public-Health Agencies
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America generated 40.45% of global sales in 2025. The United States sets the pace with mandatory real-time prescription benefit implementation scheduled for full rollout by 2027, which embeds analytic rules directly into e-prescribing workflows. Over 620,000 U.S. prescribers already use real-time prescription benefit tools. Canada's provincial health programs invest in data interoperability, and Mexico's private hospital chains deploy analytics-enabled revenue cycle platforms to counterbalance rising operating expenses.

Europe prioritizes data privacy and model transparency. The European Health Data Space allocates EUR 810 million to create a secure environment for secondary data use, enabling researchers and clinicians to exchange anonymized datasets across borders. Germany, the United Kingdom, and France devote national funding to hospital digitalization and AI pilots. Compliance with the EU Artificial Intelligence Act spurs demand for audit-ready platforms that log every algorithmic recommendation.

Asia-Pacific is the quickest-expanding region, advancing at a 29.70% CAGR. China's local governments subsidize AI-enhanced hospital systems, Japan's aging population drives telemedicine and analytics investment, and India's National Digital Health Mission underwrites data-exchange infrastructure. Australia and South Korea fund precision-medicine projects that rely on longitudinal datasets, while Singapore acts as a test-bed for regional AI governance frameworks. Brazil's 2024 Clinical Research Law accelerates approvals for digital health studies, drawing analytics vendors into Latin America.

1. Allscripts
2. Oracle
3. IBM (Merative)
4. Mckesson
5. MedeAnalytics
6. Optum
7. SAS Institute
8. Verisk Analytics
9. Epic Systems
10. Health Catalyst
11. Dimensional Insight
12. Innovaccer
13. Arcadia
14. Clarify Health Solutions
15. Change Healthcare
16. Koninklijke Philips
17. Siemens Healthineers
18. GE Healthcare
19. Qlik
20. Teradata

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Integration of Big Data & AI in Healthcare
  • 4.2.2 Growing Need for Cost Containment & Operational Efficiency
  • 4.2.3 Incentives for Value-Based Care & Outcome-Based Reimbursement
  • 4.2.4 Rise of Patient Digital Twins for Therapy Optimization
  • 4.2.5 Real-time Prescription Benefit (RTPB) Mandate Fuelling Point-of-Care Analytics
  • 4.2.6 Surge in Chronic Disease Burden
• 4.3 Market Restraints
  • 4.3.1 Data Security & HIPAA/GDPR Compliance Challenges
  • 4.3.2 Shortage of Analytics Talent in Clinical Settings
  • 4.3.3 Model Explainability Limitations Hindering Physician Trust
  • 4.3.4 High Initial Investment Costs
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value in USD)

• 5.1 By Application
  • 5.1.1 Clinical Decision Support
  • 5.1.2 Financial Analytics
  • 5.1.3 Administrative / Operational Analytics
  • 5.1.4 Research & Population Health Analytics
• 5.2 By Product
  • 5.2.1 Hardware
  • 5.2.2 Software
  • 5.2.3 Services
• 5.3 By Deployment Model
  • 5.3.1 On-Premise
  • 5.3.2 Cloud-Based
  • 5.3.3 Hybrid
• 5.4 By End User
  • 5.4.1 Healthcare Providers
  • 5.4.2 Healthcare Payers
  • 5.4.3 Pharmaceutical & Life-Sciences Companies
  • 5.4.4 Government & Public-Health Agencies
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East & Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East & Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 Allscripts Healthcare Solutions
  • 6.3.2 Oracle Corporation (Cerner Corporation)
  • 6.3.3 IBM (Merative)
  • 6.3.4 McKesson Corporation
  • 6.3.5 MedeAnalytics Inc.
  • 6.3.6 Optum Inc.
  • 6.3.7 SAS Institute Inc.
  • 6.3.8 Verisk Analytics Inc.
  • 6.3.9 Epic Systems Corporation
  • 6.3.10 Health Catalyst
  • 6.3.11 Dimensional Insight
  • 6.3.12 Innovaccer
  • 6.3.13 Arcadia
  • 6.3.14 Clarify Health Solutions
  • 6.3.15 Change Healthcare
  • 6.3.16 Philips Healthcare
  • 6.3.17 Siemens Healthineers
  • 6.3.18 GE Healthcare
  • 6.3.19 Qlik
  • 6.3.20 Teradata

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment